Bafna Pharmaceuticals standalone net profit rises 2691.60% in the September 2014 quarter

Sales decline 50.65% to Rs 23.19 crore

Net profit of Bafna Pharmaceuticals rose 2691.60% to Rs 33.22 crore in the quarter ended September 2014 as against Rs 1.19 crore during the previous quarter ended September 2013. Sales declined 50.65% to Rs 23.19 crore in the quarter ended September 2014 as against Rs 46.99 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales23.1946.99 -51 OPM %189.9114.09 -PBDT40.633.18 1178 PBT38.971.75 2127 NP33.221.19 2692

Powered by Capital Market - Live News